scholarly article | Q13442814 |
P50 | author | Nicholas John White | Q21166848 |
François Nosten | Q28033645 | ||
Joel Tarning | Q55174927 | ||
Cindy Chu | Q55175797 | ||
Mary Ellen Gilder | Q55232439 | ||
Verena I Carrara | Q56379730 | ||
Richard M Hoglund | Q91883516 | ||
Pratap Singhasivanon | Q37391387 | ||
Rose McGready | Q37609428 | ||
Germana Bancone | Q47708897 | ||
P2093 | author name string | Htun Htun Win | |
Naw Hilda | |||
Warunee Hanpithakphong | |||
P2860 | cites work | Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects | Q28550990 |
Vivax malaria: neglected and not benign | Q29619167 | ||
Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic | Q30390398 | ||
Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis | Q33654931 | ||
Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size | Q24544105 | ||
Challenges for malaria elimination in Brazil | Q26315456 | ||
Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months | Q71688779 | ||
Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission | Q33820246 | ||
Primaquine: the risks and the benefits | Q34503631 | ||
Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects | Q34597891 | ||
Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects | Q34622792 | ||
Favism: clinical and biochemical data | Q34633211 | ||
Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border | Q34764846 | ||
Primaquine revisited six decades after its discovery | Q34859798 | ||
Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects | Q34922652 | ||
Motivations and perceptions of community advisory boards in the ethics of medical research: the case of the Thai-Myanmar border | Q35095937 | ||
Maternal mortality in developing countries | Q35577039 | ||
Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects? | Q35827737 | ||
Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age | Q35867507 | ||
The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam | Q36111884 | ||
Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens. | Q36272772 | ||
High initiation and long duration of breastfeeding despite absence of early skin-to-skin contact in Karen refugees on the Thai-Myanmar border: a mixed methods study | Q36541895 | ||
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. | Q37779299 | ||
Anemia in infancy | Q37999764 | ||
Interpregnancy interval and obstetrical complications | Q38044620 | ||
The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency | Q38846685 | ||
Effects of Plasmodium vivax malaria in pregnancy | Q39309842 | ||
Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission | Q40597099 | ||
Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project | Q47246954 | ||
Enantioselective pharmacokinetics of primaquine in healthy human volunteers | Q47900510 | ||
Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed children. | Q47919920 | ||
Lack of sex effect on the pharmacokinetics of primaquine. | Q48030696 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacokinetics | Q323936 |
breastfeeding | Q174876 | ||
P577 | publication date | 2018-03-24 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures. |
Q99569236 | Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs |
Q56366262 | Expanding the use of primaquine for the radical cure of Plasmodium vivax |
Q55212289 | Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. |
Q92806422 | Tafenoquine and G6PD: a primer for clinicians |
Q92857449 | Vivax malaria in pregnancy and lactation: a long way to health equity |